Psychiatric Comorbidities and Treatment Modalities in Children With Osteogenesis Imperfecta: A Systematic Review of Mental Health
Open Access
- 10 December 2025
- journal article
- review article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 200 (4) , 777-789
Abstract
To evaluate the prevalence of psychiatric signs and symptoms and describe psychotherapeutic and psychopharmacological interventions among children with osteogenesis imperfecta (OI). PRISMA guidelines were followed, and the study was registered in PROSPERO (CRD42024588284). Studies ( n = 1419) were identified across five databases. Eligible studies, identified by independent reviewers, included peer‐reviewed research on psychiatric comorbidities or interventions in children with OI. Data extraction included study design, population characteristics, mental health outcomes, and treatment effectiveness, with all studies assessed for quality and bias. Findings were synthesized to evaluate the prevalence of psychiatric comorbidities and intervention effectiveness. Five articles met inclusion criteria after screening and full‐text review. Although the included studies varied in design and outcome measures, they reported elevated signs and symptoms of anxiety and depression in children with OI, particularly those with severe phenotypes. Qualitative findings highlighted subclinical psychosocial burdens, including emotional distress and social isolation. No studies evaluated psychotherapeutic or psychopharmacological interventions. This systematic review provides the first comprehensive analysis of psychiatric comorbidities in children with OI, revealing a critical lack of research on psychiatric comorbidities in children with OI. These gaps highlight an urgent need for targeted mental health studies to inform screening and integrated care for this population.Keywords
Funding Information
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (U54AR068069)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50HD103555)
This publication has 48 references indexed in Scilit:
- Stigmatization and Mental Health Impact of Chronic Pediatric Skin DisordersJAMA Dermatology, 2024
- Treatment Rates for Mental Disorders Among Children and AdolescentsJAMA Network Open, 2023
- A qualitative exploration of patient perspectives on psychosocial burdens and positive factors in adults with osteogenesis imperfectaAmerican Journal of Medical Genetics Part A, 2023
- Nosology of genetic skeletal disorders: 2023 revisionAmerican Journal of Medical Genetics Part A, 2023
- A multicenter study to evaluate pain characteristics in osteogenesis imperfectaAmerican Journal of Medical Genetics Part A, 2022
- Functioning and well‐being in older children and adolescents with achondroplasia: A qualitative studyAmerican Journal of Medical Genetics Part A, 2021
- Assessing physical symptoms, daily functioning, and well‐being in children with achondroplasiaAmerican Journal of Medical Genetics Part A, 2020
- Mood and suicidality outcomes 3–11 years following pediatric anxiety disorder treatmentDepression and Anxiety, 2019
- Osteogenesis Imperfecta: New Perspectives From Clinical and Translational ResearchJBMR Plus, 2019
- Quality of life in osteogenesis imperfecta: A mixed‐methods systematic reviewAmerican Journal of Medical Genetics Part A, 2015